Hepatitis C Virus Clearance: The Enigma of Failure Despite an Impeccable Survival Strategy
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
169-183
Author(s):
Maria G. Isaguliants
Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
219-236
Author(s):
James S. Chen, Douglas V. Faller and Remco A. Spanjaard
Treatment of Obesity: Should We Target the Individual or Society?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1151-1163
Author(s):
P. Antonio Tataranni
Peptidergic Regulation of Pheochromocytoma
Journal:
Current Pharmacogenomics
Volume:
1
Page:
127-137
Author(s):
Kazuhiro Takekoshi, Kazumasa Isobe, Yasushi Kawakami, Shunsuke Shibuya, Toshiaki Nakai and Yukichi Okuda
Zinc Homeostasis-regulating Proteins: New Drug Targets for Triggering Cell Fate
Journal:
Current Drug Targets
Volume:
4
Page:
323-338
Author(s):
F. Chimienti, M. Aouffen, A. Favier and M. Seve
Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1013-1022
Author(s):
B. C. Yegen
Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders
Journal:
Current Genomics
Volume:
4
Page:
295-307
Author(s):
Giorgio Sesti
CCK1R Agonists: A Promising Target for the Pharmacological Treatment of Obesity
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
837-854
Author(s):
Jerzy R. Szewczyk and Chris Laudeman
Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1103-1114
Author(s):
Arthur G. Taveras, Paul Kirschmeier and Charles M. Baum
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
239-251
Author(s):
S. Theocharis, A. Margeli and G. Kouraklis